Landauer — Investor Presentation (December 2011)
33 slides from Landauer's investor presentation, Dec 7, 2011
Slide 1: Landauer, Inc. Investor Presentation December 2011
LANDAUER, INC. Investor Presentation December 2011 Until superseded, this presentation will available at the Company website –www.landauer.com -in the Investors section.
Slide 2: Safe Harbor Statement
This presentation may contain forward-looking statements, including statements about the outlook and prospects for Company and industry growth, as well as statements about the Company’s future financial and operating performance. Some of the information shared here constitutes forward-looking statem
Slide 3: Landauer at a Glance
Landauer at a Glance 1954 Founded Glenwood, IL Headquarters 550 Employees 78,000+ Annual Customers Served 1.7 million Annual Individuals Served 94%+ Customer Retention Rates $120.5M FY2011 Revenue ~90% Recurring Revenue 20+ Consecutive Years of Revenue Growth $44.4M FY2011 EBITDA
Slide 4: Investment Highlights
Investment Highlights x Comprehensive Portfolio of Best-in-Class Service Offerings and Technology x Market Leading Positions in Attractive Segments x Global, Integrated Platform and Infrastructure x Large, Diverse Client Base Generating Recurring Revenue x Deep and Experienced Management Team x Comp
Slide 5: Landauer Strategy Overview
Value Creation Deliver Upside Growth 1.Optimize Core 2.Competitive Growth 3. Strategic Expansion Strategic Priorities Landauer Strategy Overview Strategic ExpansionOptimize the Core Competitive Growth New Management in 2006 Restructure: Cost IT/ERP system upgrades OSL / InLight –new internat
Slide 6: Radiation Safety Continuum
Radiation Safety Continuum Existing Services with Penetration Opportunities* Complementary Adjacent Products / Services _____________________ (1) Average Revenue per Facility greater than $400K. Along the Radiation Safety Continuum 6 IZI Medical Physics Core Business Greater than $1.1 Billion U.S. M
Slide 7: Transition of Landauer Financial Metrics
7 Transition of Landauer Financial Metrics FY 20125 Year Guidance Sales Mix: 2006 2007 2008 2009 2010 2011 CAGR Midpoint Radiation Monitoring 79.0$ 83.7$ 90.0$ 93.8$ 100.3$ 99.9$ 4.8% Medical Physics 14.0$ 20.6$ N/A Consumable Medical Accessories N/A Consolidated Revenue 79.0$ 83.7$ 90.0$ 93.8$ 114.
Slide 8: Long Track Record of Growth and Innovation
Long Track Record of Growth and Innovation 1954 1968 1991 1995 2003 2006 2008 2010 2009 Landauer is founded Tech/Ops Landauer changes name to Landauer, Inc. 2011 Introduces InLight® dosimetry system Signs first long- term military contract ($12M) ($ in millions) 20+ Years of Consistent Revenue Growt
Slide 9: Deep and Experienced Management Team
Deep and Experienced Management Team Name Title Prior Experience Bill Saxelby President & CEO Medical Research Laboratories Baxter International Craig Yoder, PhD SVP, Marketing & Technology Pennsylvania Power and Light Battelle, Pacific Northwest Laboratory Michael Leatherman Interim CFO Wallace Com
Slide 10: Global, Integrated Platform and Infrastructure
Global, Integrated Platform and Infrastructure 10 National Offices Subsidiaries Affiliates InLight Installations 8% 17% 75% Geographic Revenue Mix Fairborn, OH Flint, TX São Carlos, Brazil Ibaraki-ken, Japan Oxford, U.K. Beijing, China Drummoyne, Australia Fontenay-Aux-Roses Cedex, France Mexico Cit
Slide 11: Landauer Business Overview
Landauer Business Overview Investor Presentation December 2011 11
Slide 12: Radiation Safety Continuum
Radiation Safety Continuum Occupational Radiation Monitoring “Radiation Dose to Workers” x Market leader in radiation dosimetry services and equipment x Full range of products and services utilizing proprietary technology continually evolving over 50 years x Utilize proprietary OSL dosimetry technol
Slide 13: Occupational Radiation Monitoring Segment Overview
Occupational Radiation Monitoring Segment Overview Service & Product Offering Overview 84% contracted services / 16% equipment Occupational Radiation Monitoring ― Radiation exposure measurement and monitoring ― Full-service technical, analytical and client support ― Servicing healthcare, energy,
Slide 14: Occupational Radiation Monitoring: Competitive Differentiators
Occupational Radiation Monitoring Segment Overview Competitive Differentiators x Proprietary OSL (Optically Stimulated Luminescence) and InLight®technology x Immediate notification of radiation overexposure x Complete historical records for individuals monitored x Online data and account management
Slide 15: Military and Emergency Response Market Opportunity
Military and Emergency Response Market Opportunity Expanding application of next generation technology to pursue global military and first responder radiation monitoring markets The U.S. military issued orders totaling $12.5 million to upgrade the Army’s tactical dosimetry capabilities, which wi
Slide 16: Emergency Response Mutual Aid / Synchronization
Emergency Response Mutual Aid / Synchronization 16
Slide 17: Occupational Radiation Monitoring Market
$235 $365 Occupational Radiation Monitoring Market Market Dynamics / Opportunity Size / Mix x Annual growth rates of 3% to 5% (international growing faster) x Heightened awareness and concern for worker safety and more workers in contact with radiation driving increased demand x Further expansion of
Slide 18: Medical Physics Segment Overview
Medical Physics Segment Overview Service Offering Overview Full-service, national medical physics practice group ― Therapy physics ― Diagnostic physics ― Equipment commissioning services ― Accreditation support ~ 90% of revenue is recurring Provides full scope medical physics services to: ― Ho
Slide 19: Medical Physics Demand and Supply Trends
•New accreditation requirements for imaging reimbursement oMedicare and private payers oAnnual calibration and testing •Growth in equipment placement oDiagnostic imaging oLinear accelerators •Increasing physicist oversight of radiation departments •Technological improvements and complexities in imag
Slide 20: Medical Physics: Competitive Differentiators
Medical Physics Segment Overview Competitive Differentiators x Largest company in the sector with broadest reach and widest array of service capabilities — National infrastructure nearly complete x Unmatched network of board-certified and board-eligible medical physicists x Blue chip client base x 1
Slide 21: Medical Physics Areas of Expertise and Services
Therapeutic Diagnostic Nuclear Medical Area of Expertise • Radiation Treatment • Radiology/Imaging • Nuclear Medicine Overview of Responsibilities & Services Offered • Selection, acceptance testing commissioning, calibration, and annual surveys of linear accelerators (linacs), simulators, and treatm
Slide 22: Medical Physics Market
Medical Physics Market Market Dynamics / OpportunitySize / Mix x $1.0 billion domestic market (largest player in market –by 3x) x Approximately 6,000 hospitals perform 37 million nuclear medicine procedures per year (10 million in U.S.) x Radiopharmaceutical utilization growing at over 10% per year
Slide 23: IZI Medical Products
IZI Medical Products 1991 Founded Baltimore, MD Headquarters 30 Employees $14M Revenue YTD (nine months ended 9/30) 100% Recurring Revenue 1,000+ Annual Customers Served ($ in millions) History of Strong Revenue Growth Company Overview Provides high quality medical accessories used in
Slide 24: IZI Acquisition Overview
IZI Acquisition Overview In November 2011, acquired 100% of the outstanding equity of IZIMedical Products for approximately $93 million cash, subject to certain customary purchase price adjustments The acquisition is expected to be $0.12 to $0.16 accretive to EPS (earnings per share) in fiscal 2
Slide 25: IZI Medical Products Overview
IZI Medical Products Overview Spherz® ― Sterile, disposable passive reflective markers aid registration and instrument tracking during image guided surgery procedures Multi-Modality Markers ― Artificial reference points used on radiology image to provide clear and accurate reference point on sca
Slide 26: IZI Broad and Diverse Customer Base
IZI –Broad and Diverse Customer Base IZI’s customer base includes buyers at several stages along the supply chain including distributors, manufacturers of image guided navigation equipment, and product end users ― Medtronic ― Stryker ― Integra Radionics Targets community hospitals, radiation onc
Slide 27: Financial Overview
Financial Overview 27 Investor Presentation December 2011
Slide 28: Landauer Financial Overview
Landauer Financial Overview ($ in millions, FYE 9/30) Revenue ($ in millions, FYE 9/30) EBITDA Approximately 90% of revenue derived from subscription and is recurring in nature Core business growing organically in the 3% to 5% range going forward Contract with U.S. military to replace its anti
Slide 29: Recent Financial Performance
Recent Financial Performance 29 Fiscal 2011 Highlights Revenue grew 5.3 percent to $120.5 million. Gross profit grew 4.4 percent to $72.9 million on increased revenue and mix. Operating income increased $0.3 million, to $34.9 million. Net income rose 3.6 percent to $24.5 million, or $2.58 pe
Slide 30: Landauer's Strong and Stable Balance Sheet
Landauer’s Strong and Stable Balance Sheet 30 Summary Consolidated Balance Sheet (September 30, 2011) ($ in millions) Current Assets Liabilities Cash $ 7.9 Accounts Payable $ 5.4 Accounts Receivable 25.5 Dividends Payable 5.3 Other Current Assets 17.2 Deferred Income 14.7 Total Current Assets $ 50.6
Slide 31: Historical Financial Performance
*Note: Fiscal 2009 Net Income excludes $1.8M after-tax impact of charges *Note: Fiscal 2009 Net Income excludes $1.8M after-tax impact of charges Historical Financial Performance 31 Revenue, Net Income & Cash Flow from Operations ($ in Millions)
Slide 32: Competitive Dividend Policy
32 Competitive Dividend Policy Increasing Dividends per Share
Slide 33: Guidance Fiscal 2012 Outlook
Guidance 33 Fiscal 2012 Outlook Expected Revenue $150 to $157 million, which includes 10 months of contribution from the November 2011 IZI Medical Products acquisition – $4.4 million ($2.9 million net of tax) of non-recurring expense spending to support the successful completion of the Company’s s